A lawsuit filed against Gilead by 41 plaintiffs say it intentionally held back a safer HIV drug to make more profit, resulting in them suffering bone and kidney injuries.
A new class action lawsuit by an investor group accuses Gilead and other drug makers of antitrust law violations for preventing generic versions of HIV drugs.
Gilead and other drug manufacturers face a class action lawsuit claiming they conspired to keep generic HIV drugs off the market and to artificially inflate HIV drug prices.
A new study finds that the use of HIV antiviral cocktail drugs cuts transmission to zero, even as concerns over their toxicity grows.
A new study warns that Truvada, Stribild and similar HIV drugs may be causing neurocognitive degeneration in HIV-positive patients.
